Current Assets
Total Current Assets
Vertex Pharmaceuticals Total Current Assets increased by 6.0% to $11.20B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 16.7%, from $9.60B to $11.20B. Over 5 years (FY 2020 to FY 2025), Total Current Assets shows an upward trend with a 6.6% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
StatementBalance Sheet Statement
SectionCurrent Assets
CategoryLiquidity
SignalHigher is better
VolatilityModerate
First reportedQ3 2015
Last reportedQ4 2025
How to read this metric
A higher value relative to current liabilities indicates a strong safety margin for meeting short-term obligations.
Detailed definition
The sum of all assets that are reasonably expected to be converted into cash or consumed within one year. This aggregate...
Peer comparison
High-growth tech companies often maintain high current asset levels to support rapid scaling and R&D needs.
Metric ID:
total_current_assetsHistorical Data
19 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $8.46B | $8.85B | $9.56B | $10.36B | $11.50B | $12.27B | $13.23B | $12.97B | $13.87B | $14.70B | $14.14B | $13.29B | $8.94B | $9.80B | $9.60B | $10.01B | $10.43B | $10.57B | $11.20B |
| QoQ Change | — | +4.7% | +8.0% | +8.4% | +11.0% | +6.7% | +7.9% | -2.0% | +7.0% | +5.9% | -3.8% | -6.0% | -32.7% | +9.6% | -2.1% | +4.3% | +4.2% | +1.4% | +6.0% |
| YoY Change | — | — | — | — | +36.0% | +38.6% | +38.4% | +25.1% | +20.6% | +19.8% | +6.9% | +2.5% | -35.5% | -33.3% | -32.2% | -24.7% | +16.6% | +7.8% | +16.7% |
Range$8.46B – $14.70B
CAGR+6.4%
Avg YoY Growth+6.9%
Median YoY Growth+16.6%
Current Streak4 quarters growth
Total Current Assets at Other Companies
Frequently Asked Questions
- What is Vertex Pharmaceuticals's total current assets?
- Vertex Pharmaceuticals (VRTX) reported total current assets of $11.20B in Q4 2025.
- How has Vertex Pharmaceuticals's total current assets changed year-over-year?
- Vertex Pharmaceuticals's total current assets increased by 16.7% year-over-year, from $9.60B to $11.20B.
- What is the long-term trend for Vertex Pharmaceuticals's total current assets?
- Over 5 years (2020 to 2025), Vertex Pharmaceuticals's total current assets has grown at a 6.6% compound annual growth rate (CAGR), from $8.13B to $11.20B.
- What does total current assets mean?
- Everything the company owns that can be turned into cash within a single year.